AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2015
Sep 17, 2015
32566_dirs_2015-09-17_f4759ee9-8678-467d-b156-5a9e078b16f6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2015-09-16
Reporting Person: MARSH RICHARD M (E.V.P., General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-09-16 | Common Stock | M | 35000.0 | $22.93 | Acquired | 109227 | Direct |
| 2015-09-16 | Common Stock | S | 35000.0 | $41.25 | Disposed | 74227 | Direct |
| 2015-09-17 | Common Stock | F | 6684.0 | $41.39 | Disposed | 67543 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-09-16 | Non-Qualified Stock Option (right to buy) | $22.93 | M | 35000.0 | Disposed | 2018-09-10 | Common Stock (35000) | Direct |
Footnotes
F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.
F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan.
F3: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2